These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1714019)

  • 21. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
    Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
    Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic and clinical benefits with intravenous milrinone in severe chronic heart failure: results of a multicenter study in the United States.
    Anderson JL
    Am Heart J; 1991 Jun; 121(6 Pt 2):1956-64. PubMed ID: 2035427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure.
    Benotti JR; Lesko LJ; McCue JE; Alpert JS
    Am J Cardiol; 1985 Oct; 56(10):685-9. PubMed ID: 4050707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of venous tone in heart failure.
    Muir AL; Nolan J
    Am Heart J; 1991 Jun; 121(6 Pt 2):1948-50. PubMed ID: 2035425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease.
    Borow KM; Come PC; Neumann A; Baim DS; Braunwald E; Grossman W
    Am J Cardiol; 1985 Apr; 55(9):1204-9. PubMed ID: 3984901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Milrinone. A clinical trial in 29 dogs with moderate to severe congestive heart failure.
    Keister DM; Kittleson MD; Bonagura JD; Pipers FS; Knauer KW
    J Vet Intern Med; 1990; 4(2):79-86. PubMed ID: 2187984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
    Bregagnollo EA; Fortes AH; Cicogna AC
    Arq Bras Cardiol; 1999 Feb; 72(2):149-60. PubMed ID: 10488574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition.
    Klocke RK; Mager G; Kux A; Höpp HW; Hilger HH
    Am Heart J; 1991 Jun; 121(6 Pt 2):1965-73. PubMed ID: 2035428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS; Sinoway L; Chadwick B; Sonnenblick EH; Le Jemtel TH
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial and vascular actions of milrinone.
    Colucci WS
    Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
    Young RA; Ward A
    Drugs; 1988 Aug; 36(2):158-92. PubMed ID: 3053125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.
    Chang AC; Atz AM; Wernovsky G; Burke RP; Wessel DL
    Crit Care Med; 1995 Nov; 23(11):1907-14. PubMed ID: 7587268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study.
    Cesario D; Clark J; Maisel A
    Am Heart J; 1998 Jan; 135(1):121-9. PubMed ID: 9453531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Milrinone in congestive heart failure: observations on ambulatory ventricular arrhythmias.
    Holmes JR; Kubo SH; Cody RJ; Kligfield P
    Am Heart J; 1985 Oct; 110(4):800-6. PubMed ID: 4050652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
    Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.